Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Welcome to our final case of our special diabetes series intended to highlight the …
Category: Systems
Clinical Correlations
FDA Warns of Possible Link Between Chantix Therapy and Mood Disturbances
December 14, 2007
Commentary by Robert Leonard PharmD, Pharmacy Resident New York Harbor Healthcare System
On November 20, 2007 the FDA announced mounting evidence linking varenicline (Chantix®) therapy for smoking cessation with suicidal ideation and erratic and aggressive …
Meeting Perspectives: Annual Meeting of the Infectious Diseases Society of America (IDSA) October, 2007
December 13, 2007
Commentary by Neal Steigbigel MD, Professor of Medicine (Infectious Diseases/Immunology)
Methicillin resistant Staphylococcus aureus (MRSA) was a hot topic at this year’s IDSA meeting. The CA (community-acquired)-MRSA strains are spreading rapidly …
Ethical Dilemmas: Artificial Feeding
December 7, 2007
Commentary by Shrujal Baxi MD, Ethics Section Editor, and Joseph Lowy MD, Medical Director, Palliative Care Service at NYU Hospital
Mrs. Pleasant is an 85 year old woman brought into the ER by her …
Grand Rounds: “Innate Immunity and Viral Pathogenesisâ€
December 4, 2007
Commentary by Urania Rappo, PGY-2
This week’s Medicine Grand Rounds guest lecturer was Dr. Robert Finberg, currently Chair of the Department of Medicine at the University of Massachusetts Medical School. He earned his …
Grand Rounds: Breast Cancer Genomics
November 20, 2007Commentary by Jonathan Willner MD, PGY-2
This week’s Medicine Grand Rounds speaker was Lisa Carey, MD, Associate Professor in Hematology/Oncology at the University of North Carolina and Medical Director of the …
Treatment of obesity with bariatric surgery: evidence and implications
November 15, 2007
Commentary by Jatin Roper MD PGY-3 and Christine Ren MD Associate Professor, Department of Surgery
Bariatric procedures to treat obesity involve the restriction of the gastric reservoir, bypass of part of the gastrointestinal …
FDA Approves Raltegravir- A First in New Class of HIV Medications
November 14, 2007
Commentary by Helen Kourlas PharmD, Pharmacology Section Editor
On October 16th the FDA announced the approval of raltegravir (Isentress®) for the treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents. …